BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1919091)

  • 1. Relapse in leprosy after multidrug therapy and its differential diagnosis with reversal reaction.
    Reddy PK; Cherian A
    Indian J Lepr; 1991; 63(1):61-9. PubMed ID: 1919091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactions in borderline leprosy.
    Ramu G; Desikan KV
    Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological assessment of dermal nerve damage occurring during multidrug therapy for leprosy.
    Jain M; Singh N; Bhatia A; Arora VK
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):167-71. PubMed ID: 11036497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.
    Dawlah ZM; Cabrera A; Ahern K; Levis WR
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):38-43. PubMed ID: 12120041
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses in paucibacillary leprosy after MDT--a clinical study.
    Grugni A; Nadkarni NJ; Kini MS; Mehta VR
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal reaction, nerve damage and steroid therapy in three multibacillary HIV positive patients.
    Arunthathi S; Ebenezer L; Kumuda C
    Lepr Rev; 1998 Jun; 69(2):173-7. PubMed ID: 9715603
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and management of leprosy reaction in China in 2005.
    Shen J; Liu M; Zhou M; Wengzhong L
    Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of mast cells in two basic leprosy groups.
    Aroni K; Kontochristopoulos G; Liossi A; Panteleos D
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):634-5. PubMed ID: 8151199
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India.
    Lockwood DN; Vinayakumar S; Stanley JN; McAdam KP; Colston MJ
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):8-15. PubMed ID: 8326184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of relapse with drug-susceptible M. leprae after multidrug therapy.
    Constant-Desportes M; Guelpa-Lauras CC; Carolina JC; LĂ©oture A; Grosset JH; Sansarricq H
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):242-7. PubMed ID: 2071981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment of paucibacillary leprosy under multidrug therapy-three years followup study.
    Revankar CR; Karjivkar VG; Gurav VJ; Ganapati R
    Indian J Lepr; 1989 Jul; 61(3):355-9. PubMed ID: 2768883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.